|
HY-124352-1mg
|
MedChemexpress LLC
|
2-Nonyl-3-hydroxy-4-quinolone [CAS 1259944-03-0]
|
|
|
|
|
HY-125904-1mg
|
MedChemexpress LLC
|
4-Hydroxyretinoic acid [CAS 66592-72-1]
|
|
|
|
|
HY-125904-5mg
|
MedChemexpress LLC
|
4-Hydroxyretinoic acid [CAS 66592-72-1]
|
|
|
|
|
HY-N0265-1mg
|
MedChemexpress LLC
|
Asperosaponin VI [CAS 39524-08-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0265-10mg
|
MedChemexpress LLC
|
Asperosaponin VI [CAS 39524-08-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-N0265-5mg
|
MedChemexpress LLC
|
Asperosaponin VI [CAS 39524-08-8]
|
|
COVID-19-immunoregulation
|
|
|
HY-101986A-1mg
|
MedChemexpress LLC
|
BIIE-0246 (hydrochloride)
|
|
|
|
|
HY-101986-10mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101986-100mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101986-25mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101986-5mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-101986-50mg
|
MedChemexpress LLC
|
BIIE-0246 [CAS 246146-55-4]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-P71721-10ug
|
MedChemexpress LLC
|
Calreticulin/CALR, Mouse (P.pastoris, His)
|
|
|
|
|
HY-P71721-5ug
|
MedChemexpress LLC
|
Calreticulin/CALR, Mouse (P.pastoris, His)
|
|
|
|
|
HY-P71721-50ug
|
MedChemexpress LLC
|
Calreticulin/CALR, Mouse (P.pastoris, His)
|
|
|
|
|
HY-P71721Y-10ug
|
MedChemexpress LLC
|
Calreticulin/CALR, Mouse (P.pastoris, His, solution)
|
|
|
|
|
HY-P71721Y-5ug
|
MedChemexpress LLC
|
Calreticulin/CALR, Mouse (P.pastoris, His, solution)
|
|
|
|
|
HY-P71721Y-50ug
|
MedChemexpress LLC
|
Calreticulin/CALR, Mouse (P.pastoris, His, solution)
|
|
|
|
|
HY-107471-10mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
|
HY-107471-100mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
|
HY-107471-25mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
|
HY-107471-5mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
|
HY-107471-50mg
|
MedChemexpress LLC
|
CB2 receptor agonist 3 [CAS 919077-81-9]
|
|
Cancer-programmed cell death
|
|
|
HY-118798-10mg
|
MedChemexpress LLC
|
DA 3003-2 [CAS 383907-47-9]
|
|
Cancer-programmed cell death
|
|
|
HY-118798-25mg
|
MedChemexpress LLC
|
DA 3003-2 [CAS 383907-47-9]
|
|
Cancer-programmed cell death
|
|
